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A Novel Functional Interaction
between Vav and PKCu Is Required
for TCR-Induced T Cell Activation
that formation of the T cell synapse (Grakoui et al., 1999)
and assembly of productive signaling complexes de-
pend on reorganization of the actin cytoskeleton (re-
viewed in Penninger and Crabtree, 1999) and are regu-
lated, in addition, by specialized lipid microdomains
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(reviewed in Xavier and Seed, 1999).San Diego, California 92121
Vav (reviewed in Romero and Fischer, 1996; Collins²Department of Immunology
et al., 1997; Cantrell, 1998) and protein kinase C-u (PKCu;FundacioÂ n JimeÂ nez DõÂaz
reviewed in Meller et al., 1998) represent two criticalUniversidad Complutense
enzymes in the TCR signaling machinery leading to IL-2Madrid 28040
production. Analysis of Vav-deficient mice indicated thatSpain
Vav is required for T cell development and antigen re-³Department of Cell Biology
ceptor-mediated T or B lymphocyte activation (FischerThe Scripps Research Institute
et al., 1995; Zhang et al., 1995; Turner et al., 1997) asLa Jolla, California 92037
well as for TCR clustering and actin cytoskeleton reorga-
nization (Fischer et al., 1998; Holsinger et al., 1998).
Proper Vav function is also necessary for receptor-Summary
induced activation of the MAP kinase ERK and the tran-
scription factors NFAT and NF-kB and for intact Ca21Vav and PKCu play an early and important role in the
mobilization (Fischer et al., 1998; Holsinger et al., 1998;TCR/CD28-induced stimulation of MAP kinases and
Costello et al., 1999). Consistent with these findings,activation of the IL-2 gene. Vav is also essential for
Vav overexpression in T cells enhances activation ofactin cytoskeleton reorganization and TCR capping.
transcriptional elements in the IL-2 gene (Wu et al., 1995;Here, we report that PKCu function was selectively
Deckert et al., 1996), in particular NFAT.required in a Vav signaling pathway that mediates the
PKCu is a novel Ca21-independent PKC isoform (BaierTCR/CD28-induced activation of JNK and the IL-2
et al., 1993) that plays an important early role in TCR-gene and the upregulation of CD69 expression. Vav
induced activation (Meller et al., 1998). Among severalalso promoted PKCu translocation from the cytosol
PKC isoforms tested, only PKCu was capable of signifi-
to the membrane and cytoskeleton and induced its
cantly stimulating Ras-dependent transcription from an
enzymatic activation in a CD3/CD28-initiated pathway
AP-1 element in T cells (Baier-Bitterlich et al., 1996).
that was dependent on Rac and on actin cytoskeleton Furthermore, PKCu specifically cooperates with cal-
reorganization. These findings reveal that the Vav/Rac cineurin (Cn) and plays a critical role in c-Jun N-terminal
pathway promotes the recruitment of PKCu to the T kinase (JNK) activation and induction of the IL-2 gene
cell synapse and its activation, essential processes (Werlen et al., 1998; Ghaffari-Tabrizi et al., 1999). In addi-
for T cell activation and IL-2 production. tion, PKCu selectively colocalizes with the TCR/CD3
complex in the central core of the supramolecular acti-
Introduction vation complex (SMAC) that forms at the contact region
between antigen-specific T cells and antigen-presenting
T cell activation induced by triggering of the antigen- cells (APCs; Monks et al., 1997, 1998).
specific T cell receptor (TCR)/CD3 complex in concert Several recent studies indirectly suggested that Vav
with costimulatory and adhesion receptors is a complex and PKCu display some functional similarities and/or
process that involves multiple enzymes, adapters, and operate in overlapping signaling pathways. For example,
other cellular proteins. Activation is initiated by stimula- both signaling molecules can cooperate with a Ca21
tion of TCR-coupled protein tyrosine kinases (PTKs) of signal or with constitutively active Cn (CA-Cn) to activate
the Src and Syk families, which then phosphorylate vari- JNK and the IL-2 gene (Werlen et al., 1998; Villalba et
ous cellular substrates (reviewed in Weiss and Littman, al., unpublished data); PKC activation by phorbol ester
1994). This is followed by the recruitment and assembly can overcome the TCR-induced signaling defects (Fi-
of membrane signaling complexes that mediate different scher et al., 1998; Holsinger et al., 1998) and the resis-
signal transduction pathways. These signals are relayed tance to apoptosis (Kong et al., 1998) in Vav-deficient
to the nucleus, where they induce a defined genetic T cells or thymocytes, respectively. In the latter case,
program, of which the best characterized constituent is Vav was found to constitutively associate with PKCu but
the activation of the interleukin-2 (IL-2) gene by coordi- not with other PKC isoforms (Kong et al., 1998).
These findings prompted us to study possible interac-nated binding of several transcription factors to the IL-2
tions between those two signaling proteins. Here, wegene promoter (reviewed in Crabtree and Clipstone,
provide evidence that PKCu is a Vav effector in T cells1994; Jain et al., 1995). Recent studies have indicated
and that the requirement for intact PKCu function disso-
ciates two distinct Vav signaling pathways, i.e., its ability§ To whom correspondence should be addressed (e-mail: amnon@
to stimulate IL-2 gene transcription, JNK activation, andliai.org).
CD69 upregulation versus actin cytoskeleton reorgani-k Present address: INSERM UniteÂ 343, Central Immunology Labora-
tory, 06202 Nice, Cedex 3, France. zation.
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Figure 1. Interaction between Vav and PKCu
in IL-2 Promoter, AP-1, and NFAT Activation
Jurkat-TAg cells (10 3 106) were transfected
with the indicated combinations of constitu-
tively active (A/E) PKCu or a mutants (5 mg)
and/or DN Vav (DPH; 10 mg) (A, C, and E) or
with wild-type Vav (5 mg) and/or DN (K/R)
PKCu (10 mg; B, D, and E) in the presence of
an IL-2-Luc (A and B), AP-1-Luc (C and D),
or NFAT-Luc (E and F) reporter plasmid (5 mg
each). Cells were left unstimulated or stimu-
lated for the final 6 hr of culture with an anti-
CD3 mAb (OKT3; 1 mg/ml). Luciferase activity
was determined after 48 hr of culture and
normalized to the activity of a cotransfected
b-galactosidase plasmid. Maximal luciferase
activity (in arbitrary luciferase units) of the
IL-2, AP-1, or NFAT reporter in PMA-stimu-
lated plus ionomycin-stimulated cells was
21,800, 100,000, and 400,000 arbitrary lucifer-
ase units, respectively. OKT3-stimulated ac-
tivity of the NFAT reporter was 300,000 arbi-
trary luciferase units. Overexpression of the
transfected proteins was confirmed by immu-
noblotting with the corresponding PKC- or
Vav-specific antibodies ([A and B], insets).
The numbers under the different lanes corre-
spond to the transfection groups shown in
each panel. Equivalent Vav and PKC expres-
sion levels were also detected in the AP-1
and NFAT assays (data not shown).
(G) CH7C17 cells were transfected with the
indicated combinations of empty vector, Vav,
and/or NFAT reporter plasmids. After 24 hr
in culture, the cells (10 3 106/group) were
stimulated for an additional 6 hr with 2 3 106
mitomycin C±treated APCs alone or with
APCs plus HA peptide (10 mg/ml) in the ab-
sence or presence of rottlerin (10 mM) or
GoÈ 6976 (.5 mM). Luciferase activity was quan-
titated as above. The inset shows the expres-
sion levels of transfected Vav.
Results cant activation of the IL-2 promoter, which was similar
in the absence or presence of OKT3 stimulation. This
activity represented z15% of the maximal activity in-A Selective Requirement of PKCu in Vav-Induced
duced by stimulation with phorbol ester (PMA) plus iono-IL-2 Gene Activation
In order to clarify whether these two proteins function mycin. This effect of u-A/E was selective since a consti-
tutively active PKCa mutant failed to induce significantin an overlapping pathway, we evaluated the effects of
transfection with combinations of active or dominant- activity, even though it was properly overexpressed (Fig-
ure 1A, inset) and was more active than u-A/E in stimulat-negative (DN) mutants of PKCu and/or Vav on the basal
and/or anti-CD3-stimulated activity of an IL-2 promoter- ing the activity of a cotransfected ERK2 reporter (data
not shown; Werlen et al., 1998). The equal expressionreporter gene in transiently transfected Jurkat T cells.
As shown in Figure 1A, stimulation with an anti-CD3 levels of PKCu and a were confirmed by using the corre-
sponding epitope-tagged vectors in similar experimentsmonoclonal antibody (mAb; OKT3) induced minimal acti-
vation of the IL-2 promoter, consistent with findings that (Coudronniere et al., 2000). Transient overexpression of
VavDPH, a DN Vav mutant whose pleckstrin-homologyoptimal induction of this promoter requires combined
stimulation with an anti-CD3 antibody plus phorbol ester (PH) domain has been deleted (Villalba et al., unpub-
lished data), blocked both the basal and OKT3-induced(Crabtree and Clipstone, 1994; Jain et al., 1995). A con-
stitutively active PKCu mutant, u
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cells. In contrast, the same Vav mutant only partially
reduced the u-A/E-induced promoter activity under ei-
ther basal (30% inhibition) or stimulated (50% inhibition)
conditions.
As reported earlier (Wu et al., 1995), transient Vav
overexpression stimulated the basal activity of the IL-2
promoter and enhanced the anti-CD3-induced activity
(Figure 1B). However, Vav was less active than u-A/E
(compare Figure 1A versus 1B). A DN PKCu mutant
(u-K/R) blocked the promoter activity induced by OKT3
stimulation and/or transfected Vav. This effect was se-
lective since, under similar conditions, the same u-K/R
mutant did not inhibit the ability of Vav to promote actin
polymerization (Figure 4B). Immunoblotting with anti-
PKCu or -Vav antibodies confirmed the overexpression
of the relevant proteins in the appropriate transfection
groups (Figures 1A and 1B, insets). These findings sug-
gest that functional PKCu is required for TCR- and/or
Vav-stimulated promoter activity and tentatively place
PKCu downstream of Vav or in an essential pathway
that acts in parallel to Vav.
Similar to their effects on the IL-2 promoter, u-A/E
and Vav were each capable of activating the AP-1 (Fig-
ures 1C and 1D) or NFAT (Figures 1E and 1F) reporters,
respectively. PKCu-A/E was much more effective than
Vav in inducing AP-1 activity (compare Figure 1C versus
1D) but, conversely, Vav was a more potent activator of
NFAT than u-A/E (compare Figure 1F versus 1E). As in
the case of the IL-2 promoter, the stimulatory effect of
u-A/E was specific since a-A/E failed to stimulate AP-1
or NFAT and VavDPH failed to significantly inhibit the
u-A/E-induced activities of these two reporters (Figures
1C and 1E). In contrast, the DN PKCu mutant blocked
the Vav-induced reporter activity (Figures 1D and 1F).
We were unable to address in an informative manner the
Figure 2. Interactions between Vav and PKCu in JNK Activation
effect of VavDPH on PKCu-A/E-induced NFAT activity in
(A) PKCu is downstream of Vav in the pathway leading to JNK activa-
activated cells since PKCu-A/E consistently inhibited tion. Jurkat-TAg cells were transfected with an HA-JNK1 plasmid
the anti-CD3-stimulated NFAT activity. The reason for (5 mg) together with CA-Cn, CA-PKCu, and Vav or with 10 mg of DN-
this is unclear, but it may be related to the observed PKCu or DN-Vav. After 2 days, HA-JNK was immunoprecipitated
with an anti-HA antibody and JNK kinase activity was determinedinhibition of Ca21-dependent NFAT activity in T cells by
by an in vitro immune complex kinase assay. Under the same condi-constitutively active Ras (Chen et al., 1996) since our
tions, DN-PKCu blocked the anti-CD3 plus CD28-induced activationprevious work established a functional connection be-
of JNK (data not shown). These results are representative of threetween PKCu and Ras (Baier-Bitterlich et al., 1996).
similar experiments.
The biological relevance of these findings was further (B) Vav and PKCu do not cooperate to activate JNK in T cells. Cells
established by using a previously characterized antigen- were transfected and analyzed as in (A). As a control, some cells
dependent activation system, i.e., variant Jurkat cells were stimulated for 15 min with PMA (100 ng/ml) plus ionomycin (1
mg/ml). Results represent the mean 6 SD of three experiments.(CH7C17) that stably express an ab-TCR specific for a
(C) Vav and PKCu synergize to activate JNK in nonhematopoietichemagglutinin (HA)-derived peptide (Hewitt et al., 1992).
cells. 293T cells (1 3 106) were transfected with the indicated plas-Stimulation of these cells with peptide plus APCs in-
mids plus HA-JNK1 (5 mg each). JNK kinase activity (top panel) orduced activation of the NFAT reporter, which was further
its expression level (bottom panel) were determined as described
enhanced by transient Vav overexpression (Figure 1G). in (A) and (B). The numbers above each lane represent the fold
Rottlerin, a selective inhibitor of PKCu (Villalba et al., activation of JNK relative to the empty vector-transfected group
1999a; Coudronniere et al., 2000), blocked antigen- (51), as determined by phosphorimager analysis.
induced NFAT activation and reduced it to a level lower
than the basal activity in unstimulated cells. In contrast,
T cell±expressed PKCs in its ability to activate JNK andGoÈ 6976, an inhibitor selective for Ca21-dependent PKC
to cooperate with CA-Cn (Werlen et al., 1998; Ghaffari-isoforms (Villalba et al., 1999), caused minimal inhibition
Tabrizi et al., 1999). Therefore, we ascertained the inter-of NFAT activation (Figure 1G).
relationship between PKCu and Vav with regard to JNK
activation. Transient coexpression of Vav and CA-CnRelationship between Vav and PKCu
induced significant activation of a cotransfected JNKin JNK Activation
plasmid (Figure 2A), and, moreover, this activation wasVav cannot efficiently activate JNK in T cells, but it can
completely blocked by coexpressed u-K/R. On the othercooperate with CA-Cn to do so (Villalba et al., unpub-
lished data). On the other hand, PKCu is unique among hand, u-A/E by itself also activated JNK, but VavDPH
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failed to inhibit this effect. The same Vav mutant inhib-
ited, however, JNK activation induced by anti-CD3 plus
anti-CD28 stimulation (Villalba et al., unpublished data).
In addition, Vav or CA PKCu cooperated with CA-Cn
but not with each other to induce JNK activity (Figure
2B). This lack of cooperation between Vav and PKCu
favors the idea that PKCu acts downstream of Vav in
the same (or a partially overlapping) pathway leading
to JNK activation and, furthermore, that this pathway
cooperates with Ca21/Cn signals. This is consistent with
the two-signal requirement for JNK activation in T cells
(Su et al., 1994; Werlen et al., 1998).
Since this two-signal requirement is unique to T cells
(Su et al., 1994) and neither PKCu (Werlen et al., 1998)
nor Vav (Villalba et al., unpublished data) cooperate with
Cn in nonhematopoietic cells, it might be predicted that
ectopic expression of Vav plus PKCu will result in a
cooperative effect in cells that lack both proteins. To
test this possibility, we analyzed the effects of Vav and/
or PKCu on the activity of a cotransfected JNK reporter
in heterologous 293 cells (Figure 2C). Each of these
proteins stimulated the activity of JNK compared to the
empty vector-transfected cells (lanes 2±4 versus lane
1). When the two were combined, synergistic effect was
observed (lanes 5 and 6). No significant difference was
observed between wild-type and constitutively active
PKCu, perhaps reflecting the possibility that normal
PKCu regulatory mechanisms are absent in 293 cells.
Nevertheless, PKCu activity was essential for JNK acti-
vation since the kinase-inactive u-K/R, either alone or
Figure 3. Vav Upregulates CD69 Expression via a Selective, PKCu-
in combination with Vav (data not shown), failed to stim- Dependent Pathway
ulate JNK activity in 293 cells. Similar to Vav, a constitu- Jurkat-TAg cells were transfected with empty vector, Vav, or Vav
tively active Rac mutant (RacV12) also synergized with plus the indicated DN PKC mutants (5 mg each) in the presence of
PKCu to activate JNK (lanes 7±10). A constitutively ac- pEF-GFP. CD69 expression was determined 2 days later by FACScan
analysis of GFP-gated cells. The results are displayed as histogramstive Cdc42 mutant (Cdc42V12) behaved in a similar man-
(A) or as average percentage of CD69-positive cells 6 SE in threener (data not shown).
separate experiments (B). As a positive control, one group of cells
was transfected with CA-Ras (RasL61) to induce CD69 expression (B).
Specific Inhibition of Vav-Mediated CD69
Upregulation by DN PKCu
We recently found that transient overexpression of ei-
cytoskeleton (Fischer et al., 1998; Holsinger et al., 1998;ther Vav (Figure 3A) or constitutively active PKCu (data
Kong et al., 1998; Penninger and Crabtree, 1999). Asnot shown) upregulates the expression of the activation
shown in Figure 4A, transient Vav overexpression in-antigen CD69 in Jurkat T cells. The biological relevance
creased the F-actin content and its accumulation in theof this novel finding is indicated by the report that Vav2/2
submembranous area, which was similar to the effectthymocytes display a defect in CD69 expression follow-
induced by anti-CD3 stimulation. This effect was sensi-ing TCR/CD3 stimulation (Fischer et al., 1995) and, fur-
tive to cytochalasin D, which disrupts the actin cy-thermore, by our finding that the Vav-induced CD69
toskeleton.upregulation was dependent on functional Ras (Villalba
Next, we determined whether Vav-induced actin poly-et al., unpublished data ), similar to the TCR/CD3-induced
merization was dependent on PKCu by quantitating theexpression of CD69 (D'Ambrosio et al., 1994). We deter-
binding of phalloidin to F-actin. Transient Vav overex-mined whether PKCu is also required for Vav-mediated
pression increased the amount of F-actin in either un-CD69 upregulation by assessing the effects of DN PKCu.
stimulated or anti-CD3-stimulated T cells (Figure 4B). InCoexpression of u-K/R inhibited the effect of Vav by
contrast to the selective requirement of PKCu for Vav-z90%. In contrast, DN mutants of other PKC isoforms,
induced transcriptional activation (Figure 1), JNK activa-which were properly overexpressed in the cells (data
tion (Figure 2), or CD69 upregulation (Figure 3), DN PKCunot shown), failed to cause a significant inhibition of
consistently failed to significantly reduce the Vav-medi-Vav-induced CD69 expression (Figure 3). As a positive
ated actin polymerization in unstimulated or anti-CD3-control (D'Ambrosio et al., 1994), a constitutively active
activated cells (Figure 4B, left panel). Similarly, transientRas mutant (RasL61) also upregulated the expression
overexpression of u-K/R alone also did not interfere withof CD69.
the OKT3-stimulated F-actin accumulation. Consistent
with these findings, the selective PKCu inhibitor (rott-Vav-Induced Actin Cytoskeleton Reorganization
lerin; Figure 1G) did not significantly inhibit Vav- or anti-Is Independent of PKCu
CD3-induced actin polymerization (data not shown).Vav is required for TCR clustering, reflecting its ability
to promote Rac-dependent reorganization of the actin These results indicate that Vav participates in at least
Vav Regulates PKCu Function in TCR Signaling
155
Figure 4. Vav Regulation of Actin Polymer-
ization Is PKCu Independent
(A) Empty vector (pEF)-transfected Jurkat T
cells were left unstimulated or activated with
OKT3 for 1 min (left and right upper panels,
respectively). Another group of cells was
transfected for 48 hr with Vav, and a portion
of these cells was treated with cytochalasin
D (10 mg/ml). The cells were fixed and perme-
abilized, and F-actin was visualized by TRITC-
phalloidin staining and immunofluorescence
microscopy.
(B) Jurkat-TAg cells (10 3 106) were cotrans-
fected with the indicated combinations of Vav
(5 mg) DN (K/R) or CA (A/E) PKCu or a mutants
(10 mg each) plus pEF-GFP (5 mg). Half of
the cells in each group were stimulated with
OKT3 (1 mg/ml) for the final 10 min of culture.
After 2 days, the cells were fixed and analyzed
for F-actin content as in (A). The results are
displayed as percentage increase in mean
fluorescence intensity relative to empty vec-
tor-transfected, unstimulated cells, and rep-
resent the mean 6 SD of three (left panel) or
two (right panel) experiments.
two distinct signaling pathways, i.e., a PKCu-dependent (Figure 5B). We ascertained whether transient Vav over-
pathway that upregulates CD69 and activates JNK and expression could promote a similar translocation of
the IL-2 gene and a PKCu-independent pathway that PKC. Jurkat cells were transfected with Vav, and the
mediates actin polymerization and, therefore, is most distribution of endogenous PKCu, a, e, and z among the
likely involved in TCR/CD3 capping (Penninger and cytosol, membrane, and detergent-insoluble fractions
Crabtree, 1999). The independence of the latter pathway was determined by immunoblotting. The results (Figure
on PKCu is further supported by the finding that, unlike 5C) show an increase in the membrane and cytoskeletal
Vav, transient overexpression of constitutively active fractions of PKCu relative to its cytosolic content, but
PKCu failed to induce significant F-actin accumulation not of the other PKC isoforms, in the Vav-transfected
(Figure 4B, right panel). cells. This selective translocation of PKCu is evident
after quantitation of the PKC signals (Figure 5D). In con-
Vav Promotes the Selective Membrane trast to the selective effect of Vav, PMA treatment in-
Translocation of PKCu duced cytosol-to-membrane translocation of PKCu, a,
A recent study reported an association between PKCu and e but had no effect on PKCz, which is unresponsive
and Vav (Kong et al., 1998). However, numerous coim- to PMA (Ohno et al., 1989). The effect of Vav on PKCu
munoprecipitation experiments using anti-Vav or -PKCu localization probably represents an underestimate since
antibodies failed to demonstrate detectable association only a fraction of the cell population expressed the trans-
between these two proteins either before or after stimu- fected Vav vector.
lation with anti-CD3 and/or anti-CD28 antibodies (Figure Next, we cotransfected Jurkat cells with an epitope-
5A), even when they were overexpressed by transient tagged PKCu expression vector plus wild-type or DN
transfection. Under the same conditions, the association
(DPH) Vav and analyzed the expression of the trans-
between Vav and the adapter protein SLP-76 (Wu et al.,
fected PKCu in different subcellular fractions by immu-1996) and its upregulation by T cell activation could be
noblotting with an anti-Xpress tag mAb (Figure 5E). Thereadily demonstrated (Figure 5A). It is, therefore, possi-
results clearly indicate that anti-CD3 stimulation as wellble that the reported Vav-PKCu association (Kong et al.,
as Vav coexpression caused a similar redistribution of1998) is a unique feature of immature T cells.
the cotransfected PKCu from the cytosol to the mem-PKCu activation is associated with its membrane and
brane and cytoskeleton fractions. More importantly, thecytoskeletal translocation (Meller et al., 1996) as well as
basal expression of PKCu in the membrane and cy-with its colocalization with the TCR to the contact site
toskeleton and, in particular, its OKT3-induced translo-between antigen-specific T cells and APCs (Monks et
cation to the same fractions was severely reduced byal., 1997). Consistent with this, costimulation of Jurkat
coexpressing a DN Vav mutant (second panels fromT cells with anti-CD3 plus anti-CD28 antibodies induced
bottom). In addition, the effect of wild-type Vav wasa time-dependent translocation of PKCu from the cy-
reversed by coexpressing a DN Rac mutant (bottomtosol to the membrane and detergent-insoluble (cyto-
skeleton) subcellular fractions, which peaked at 10 min panels). We confirmed these effects of Vav by using
Immunity
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Figure 5. Vav Induces Membrane and Cytoskeleton Translocation of PKCu
(A) Jurkat-TAg cells were transfected with empty vector (pEF) or pEF-c-Myc-Vav (10 mg) and left unstimulated or activated with OKT3 for the
final 2 min of a 48 hr culture. The cells were lysed, and Vav was immunoprecipitated with an anti-c-Myc mAb. The immunoprecipitates, or a
sample of the cell lysate, were analyzed by immunoblotting with anti-PKCu or -SLP-76 antibodies. Similar results were obtained in several
experiments.
(B) Jurkat cells were stimulated with anti-CD3 plus anti-CD28 antibodies for the indicated times. Cytosol, membrane, and detergent-insoluble
fractions were prepared, resolved by SDS-PAGE, and the expression of PKCu in each fraction was determined by immunoblotting with a
specific antibody. These results are representative of five similar experiments.
(C) Vav induces selective translocation of endogenous PKCu to the membrane and cytoskeleton. Jurkat-TAg cells (20 3 106) were transfected
with empty vector (pEF) or Vav (5 mg each) and lysed after 40 hr. Cytosol (C), membrane (M), and detergent-insoluble (I) cell fractions were
prepared, resolved by SDS-PAGE, and expression of the indicated endogenous PKC isoforms in each fraction was analyzed by immunoblotting
with the corresponding isoform-specific antibodies (left panels). As a positive control for PKC translocation, a portion of the cells in each
transfection group was stimulated with PMA (100 ng/ml) for the final 10 min of culture (right panels). The same protein amounts from each
fraction were loaded in each lane. Similar findings were obtained in a separate experiment.
(D) PKC signals from the unstimulated cells in (C) were quantitated by scanning densitometry, normalized to an equal cell number in each fraction,
and the membrane-to-cytosol (M/C) or cytoskeleton-to-cytosol (I/C) PKC ratios were calculated. The results are displayed as percentage of
increase/decrease of the PKC ratio in the Vav-transfected cells relative to pEF-transfected cells.
(E) PKCu translocation is regulated by Vav. Jurkat-TAg cells (20 3 106) were transfected with the indicated combinations of wild-type Vav (5
mg), DN-Vav (DPH), and/or DN-Rac (RacN17) (10 mg each) together with an Xpress-tagged PKCu plasmid (5 mg). A portion of the cells in each
group was stimulated with OKT3 (1 mg/ml) for the final 10 min of culture. Cells were lysed and fractionated as in (C), and expression of the
transfected PKCu in each fraction was determined by anti-Xpress immunoblotting. These results are representative of three similar experiments.
confocal microscopy to follow the localization of a trans- transient Vav overexpression enhanced the redistribu-
tion of PKCu into clustered membrane lipid rafts (K. Bifected recombinant protein consisting of the regulatory
domain of PKCu fused to green fluorescent protein and A. A., unpublished data). Taken together, the results
in Figures 5 and 6 indicate that Vav-dependent signals,(GFP). Similar constructs of other PKCs were found to
mimic the behavior of native PKC and its stimulus- which most likely reflect its regulation of the actin cy-
toskeleton (Figure 4), are important for the translocationdependent response (Oancea and Meyer, 1998). F-actin
distribution was followed in parallel by phalloidin stain- of PKCu from the cytosol into compartments where it
can potentially interact with the TCR signaling machin-ing. As reported (Meller et al., 1996), a fraction of PKCu-
GFP localized to the membrane in unstimulated Jurkat ery (Monks et al., 1997) and mediate its biological activ-
ities.cells (Figure 6, top right panel). PMA stimulation (middle
right panel) as well as Vav overexpression (bottom right
panel) induced increased translocation and a more gran-
ular appearance of PKCu to the membrane and sub- Vav Activates PKCu and Is Involved in
Receptor-Mediated PKCu Activationmembranous area, and this coincided with the redistri-
bution of F-actin in the same cells (left panels). A similar In order to determine whether the Vav-induced translo-
cation of PKCu to the membrane and cytoskeleton isresult was obtained when heterologous 293 cells were
cotransfected with Vav and the PKCu-GFP plasmids associated with its enzymatic activation, we performed
immune complex kinase assays of PKCu isolated from(data not shown). Consistent with this effect of Vav,
Vav Regulates PKCu Function in TCR Signaling
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Figure 7. A Vav/Rac/Cytoskeleton Pathway Mediates Receptor-
Stimulated PKCu Activation
(A) Jurkat-TAg cells were transfected with 5 mg empty vector, Vav,
or CA-Rac (RacV12). Endogenous PKCu or PKCa was immunopre-
cipitated after 40 hr, and enzymatic activity was determined by an
in vitro kinase reaction using MBP as a substrate (top panels). The
kinase reactions were performed in the absence of lipid cofactors
or PMA to reflect the in situ activity of the kinases (Monks et al.,
1997). Aliquots of the immunoprecipitates were immunoblotted with
the corresponding PKC-specific antibodies to confirm the similarFigure 6. Vav Induces Membrane Translocation of a PKCu-GFP Fu-
expression levels of PKCu or a in different groups (bottom panels).sion Protein
(B) Jurkat-TAg cells were transfected with the indicated plasmids
Jurkat-TAg cells were transfected with empty vector (pEF) or Vav and were either left unstimulated or stimulated with anti-CD3 plus
(5 mg each) together with 5 mg of a PKCu regulatory domain-GFP anti-CD28 antibodies for the final 10 min of culture. Some groups
expression plasmid. After 2 days, GFP localization was analyzed by were pretreated with cytochalasin D (10 mg/ml) as indicated. PKCu
confocal imaging. Some cells were stimulated for the final 10 min activity (top panel) or expression levels (bottom panel) were deter-
of culture with PMA (100 ng/ml) as a positive control for PKCu mined as in (A). Similar results to those in (A) and (B) were obtained
translocation. F-actin localization in the same cells was revealed by in two additional experiments.
phalloidin staining. These images are representative of 80% of the
pEF-transfected cells (43/50 cells observed), 95% of the PMA-stimu-
lated cells (26/27 cells observed), and 75% of the Vav-transfected
cells (32/41 cells observed). with APCs, a process that depends on reorganization
of the actin cytoskeleton (Penninger and Crabtree, 1999)
and on the selective accumulation of the TCR/CD3 com-empty vector-transfected cells or from cells cotrans-
plex and associated signaling molecules within mem-fected with Vav or a CA Rac (RacV12) mutant. The kinase
brane lipid rafts (Xavier and Seed, 1999). Our findingsassays were performed in the absence of the activating
reveal a novel role for Vav in the recruitment of PKCulipid cofactors in order to assess the in situ activity of
to the relevant membrane/cytoskeletal compartments,PKC (Monks et al., 1997). Vav as well as RacV12 induced
where it needs to localize in order to become activatedactivation of PKCu, and this effect was selective since
and promote TCR-initiated proliferation (Monks et al.,activation of PKCa was not detected (Figure 7A).
1997, 1998). The relevance of these results to physiologi-Finally, we analyzed the effects of DN Vav (VavDPH)
cal events associated with TCR/CD3-mediated T cellor Rac (RacN17) mutants on the anti-CD3/CD28-stimu-
activation is established by the following: the ability oflated activation of PKCu. This stimulation induced a
DN Vav or PKCu mutants to inhibit CD3 or CD3/CD28-readily detectable activation of PKCu (Figure 7B; lane 2
mediated transcriptional activation (Figure 1) or JNKversus lane 1). However, PKCu activation was blocked
activation (Werlen et al., 1998; Villalba et al., unpublishedwhen the cells were cotransfected with the DN Vav (lane
data); the inhibition of antigen- and/or Vav-induced3) or Rac (lane 4) mutants. For comparison, cytochalasin
NFAT activity by a selective PKCu inhibitor (Figure 1G);D pretreatment also blocked the ability of the antibodies
the translocation and activation of PKCu induced byto induce PKCu activation (lane 5) or actin polymeriza-
physiological CD3/CD28 stimulation (Figure 5A), whichtion (Figure 4A). Nearly equal amounts of PKCu were
is mimicked by Vav (Figures 5B±5D and 6); and theexpressed in all groups (Figure 7B, bottom panel).
inhibition of receptor-induced PKCu translocation (Fig-
ure 5D) or activation (Figure 7B) by DN Vav or Rac andDiscussion
by cytochalasin D. Taken together, all of these findings
and, in particular, the similarities between the actionsProductive T cell activation requires the proper assem-
of Vav and PKCu at the level of transcriptional stimula-bly and formation of the T cell SMAC (Monks et al., 1998)
or synapse (Grakoui et al., 1999) in the contact region tion, JNK activation, and CD69 upregulation suggest
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that Vav and PKCu are components of the same signal- recently emerging view that Vav independently regu-
lates different signaling pathways, including growth anding pathway. Moreover, the findings that the above func-
tional effects induced by Vav are blocked by DN PKCu cytoskeleton reorganization pathways (Cantrell, 1998;
Fischer et al., 1998). It is also consistent with the findingsbut not vice versa indicate that PKCu can be functionally
placed downstream of Vav in this pathway. that distinct functions of the Vav effectors, Rac or
Cdc42, i.e., their ability to induce reorganization of theDespite these similarities, there are some notable dif-
ferences between Vav and PKCu. Thus, PKCu is consid- actin cytoskeleton and JNK activation versus the activa-
tion of PAK, can be dissociated by mutations in theirerably more efficient than Vav in stimulating the IL-2
gene promoter and particularly AP-1 in unstimulated effector domains (Lamarche et al., 1996).
The major novel aspect of our study is the functionalcells; conversely, Vav is a more potent inducer of NFAT
activity. We attribute these differences to the fact that linkage of PKCu to Vav and Rac in the T cell growth
regulatory pathway and the apparent absolute depen-PKCu is an effective activator of the Ras/JNK/AP-1 path-
way (Baier-Bitterlich et al., 1996; Werlen et al., 1998; dence of Vav on intact PKCu function in this pathway.
This link between Vav and PKCu provides a mechanisticGhaffari-Tabrizi et al., 1999) but, most likely, does not
have a role in activating the Ca21/Cn pathway; in con- basis for the implied connection between these two
proteins suggested recently by Penninger and Crabtreetrast, Vav is a weak inducer of the Ras/JNK pathway
(Villalba et al., unpublished data), but it plays an impor- (1999). However, since we failed to confirm the reported
(Kong et al., 1998) physical association between Vavtant role in activating the Ca21/Cn pathway (Fischer et
al., 1998; Holsinger et al., 1998; Costello et al., 1999), and PKCu (Figure 5A), it is likely that, at least in our
system, PKCu is functionally but not physically linkedwhich is essential for NFAT induction (Rao et al., 1997;
Crabtree, 1999). Based on these differences, we favor to Vav. It is possible that the reported association be-
tween Vav and PKCu (Kong et al., 1998) reflects theirthe view that Vav and PKCu function in overlapping but
not identical pathways. One pathway, which is shared localization to the same membrane microdomains and/
or cytoskeletal structures, rather than a direct physicalby both signaling proteins, mediates transcription factor
and JNK activation as well as CD69 upregulation. How- interaction.
The model proposed herein provides a commonever, each of these proteins uniquely regulates other
nonoverlapping signaling events (Collins et al., 1997; mechanistic basis for several recent findings concerning
the assembly and organization of the T cell synapseMeller et al., 1998).
Despite being able to block transcriptional activation, (Grakoui et al., 1999) or SMAC (Monks et al., 1998): first,
the selective antigen-induced activation and localizationJNK stimulation, and CD69 upregulation (Figures 1±3),
DN PKCu has no detectable effect on the Vav- or anti- of PKCu to the contact site between antigen-specific T
cells and APCs (Monks et al., 1997); second, the selec-CD3-induced F-actin accumulation (Figure 4B). The
most plausible model to explain this finding is as follows: tive role of PKCu in JNK, AP-1, and IL-2 induction (Baier-
Bitterlich et al., 1996; Werlen et al., 1998; Ghaffari-Tabrizifirst, TCR/CD28 stimulation activates tyrosine kinases,
which, in turn, activate Vav via its tyrosine phosphoryla- et al., 1999); third, the importance of Vav in reorganizing
the T cell actin cytoskeleton and TCR cap (Fischer ettion in a process that is not strictly dependent on actin
cytoskeleton reorganization. This is consistent with the al., 1998; Holsinger et al., 1998); fourth, its accumulation
in the same lipid rafts where the TCR complex and vari-findings that early tyrosine phosphorylation events are
intact in cytochalasin D±treated normal T cells or in Vav- ous signaling elements, including (presumably) PKCu
(Monks et al., 1997), are found (Xavier and Seed, 1999);deficient T cells (Fischer et al., 1998; Holsinger et al.,
1998). Second, activated Vav induces actin polymeriza- and, finally, the ability of Vav to independently regulate
actin polymerization and growth signals (our findingstion and TCR capping via Rac/Cdc42, and this process
does not require functional PKCu. However, these Vav- herein; Miranti et al., 1998). The availability of Vav-defi-
cient mice and the anticipated generation of PKCu-defi-induced events are essential for the translocation of
PKCu and its colocalization with the TCR in the T cell cient mouse lines will now make it possible to test sev-
eral experimental predictions that can be formulatedSMAC (Monks et al., 1997, 1998) as well as for its enzy-
matic activation. Direct or indirect association of PKCu based on the model emerging from our findings.
with a cytoskeletal protein could represent one mecha-
nism through which Vav may promote PKCu transloca-
Experimental Procedures
tion and activation. Finally, the Vav/Rac-induced mem-
brane recruitment of PKCu induces its activation and, Antibodies and Reagents
Polyclonal rabbit antibodies against PKCu and JNK and the anti-consequently, activation of JNK and the IL-2 gene as
Myc mAb (9E10) were obtained from Santa Cruz Biotechnology.well as upregulation of CD69. The dependence of this
PKCu-, a-, e-, or z-specific mAbs were obtained from Transductionpathway on intact PKCu function reflects the essential
Laboratories. The anti-CD3 mAb (OKT3) was purified as previously
role of a Vav/Rac pathway in inducing PKCu membrane described (Villalba et al., 1999a). The anti-human CD28 and phycoer-
localization and activation. It would be interesting to ythrin (PE)-conjugated anti-human CD69 mAbs were from Phar-
determine whether this represents an alternative PKCu Mingen. The anti-HA (clone 12CA5) and -Xpress tag mAbs were
obtained from Roche Molecular Biochemicals and Invitrogen, re-activation mechanism that is independent of PLCg1 acti-
spectively. The anti-phospho-c-Jun polyclonal antibody was fromvation and diacylglycerol production.
New England Biolabs, and the anti-human Vav mAb was from Up-According to this model, Vav independently regulates
state Biotechnology. Donkey anti-rabbit or sheep anti-mouse IgG
different T cell functions, as would be expected from its antibodies were obtained from Amersham. Rottlerin and GoÈ 6976
domain structure and multifunctional nature (Collins et were purchased from Calbiochem. All other reagents were obtained
from Sigma.al., 1997). This notion is generally consistent with the
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Plasmids 100 mM ATP, and 2 mg of myelin basic protein (MBP) as substrate.
Samples were incubated for 20 min at 308C with gentle shaking.The cDNAs encoding human wild-type PKCu and a, the correspond-
ing constitutively active (A/E) mutants, and the DN (kinase-inactive; The reaction was stopped by adding 20 ml of 23 Laemmli buffer.
Samples were incubated at 1008C for 5 min and subjected to SDS-K/R) mutants of these PKCs as well as rat PKCe and mouse PKCz
in the eukaryotic expression vector pEFneo have been described PAGE and autoradiography. [g-32]ATP incorporation was determined
using a STORM 860 PhosphorImager (Molecular Dynamics).(Villalba et al., 1999). To generate an epitope-tagged version of
PKCu, the PKCu plasmids were subcloned into the BamHI and XbaI Transfected JNK1 was immunoprecipitated with an anti-HA mAb
as described above, and its activity was assayed in 20 ml of JNKsites, respectively, of the pEF4/His-C mammalian expression vector
(Invitrogen) by standard techniques. This vector encodes in-frame kinase buffer (25 mM HEPES [pH 7.5], 25 mM MgCl2, 25 mM
b-glycerophosphate, 1 mM DTT, and 0.1 mM Na3VO4) for 20 min atHis6 and Xpress tags upstream of the insert. The construction of
c-Myc-tagged Vav expression plasmids in the pEF vector was de- 308C with gentle shaking, using 2 mg of GST-c-Jun as a substrate.
Reactions were stopped and processed as described above.scribed (Villalba et al., unpublished data). Briefly, the PH domain of
wild-type Vav cDNA (Deckert et al., 1996) was deleted (DPH) by
digesting the corresponding cDNA with NgoMI and BspEI, thereby CD69 Expression
Cells were transfected with the indicated vectors plus a GFP expres-excising a fragment encoding residues 403±507 of Vav. An HA-
tagged, constitutively active calcineurin A mutant (CA-Cn), a CA sion plasmid and harvested 2 days later. The cells were washed in
RPMI-1640 medium and suspended in 500 ml of RPMI-1640 plusRas (RasL61) mutant, CA (RacV12) or DN (RacN17) Rac mutants (all
in the pSRa vector), and HA-tagged JNK1 in pCDNA3 were obtained 20 ml of PE-conjugated anti-human CD69 mAb for 15 min. CD69
expression was analyzed by flow cytometry (FACScan, Becton andfrom Dr. M. Karin and have been described (Werlen et al., 1998;
Villalba et al., unpublished data). An expression vector encoding the Dickinson) after gating on GFP-positive cells.
regulatory domain of PKCu fused to the N terminus of GFP was a
generous gift from Dr. J. Neefjes and E. Reits (The Netherlands Actin Polymerization
Jurkat-TAg cells (10 3 106 per condition) were transfected with theCancer Institute, Amsterdam). This plasmid was generated by PCR-
mediated amplification of the PKCu regulatory domain and its liga- indicated Vav or PKCu vectors plus 5 mg pEF-GFP and cultured for
36 hr in the absence or presence of cytochalasin D (10 mM). Thetion into the pEGFP-N1 vector (Clontech). A GFP expression plasmid
in the pEF vector was obtained from Dr. G. Baier (University of cells were collected, washed, resuspended in RPMI plus 10% FBS,
and prewarmed for 15 min at 378C. Some groups were stimulatedInnsbruck). As control for transfection efficiencies, a b-galactosi-
dase (b-gal) expression plasmid in the pEF vector was used. with an anti-CD3 mAb (OKT3; 5 mg/ml) for the indicated times. Reac-
tions were stopped by adding 1 ml of 3.7% paraformaldehyde in
PBS and incubating for 15 min at room temperature, followed byCell Culture and Transfection
blocking with PBS/1% BSA/0.1% NaN3 under the same conditions.Simian virus 40 large T antigen±transfected human leukemic Jurkat
Following centrifugation (2000 rpm, 3 min), the pellet was carefullyT (Jurkat-TAg) cells were grown in RPMI 1640 medium (Life Technol-
resuspended in PBS/1% BSA/0.1% NaN3/0.05% saponin and incu-ogies), supplemented with 10% fetal bovine serum (FBS), 2 mM
bated for 30 min at 48C in order to permeabilize the cells. The cellsglutamine, 1 mM sodium pyruvate, 10 mM HEPES, 13 MEM nones-
were centrifuged again, resuspended in the same solution plus 100sential amino acid solution (Life Technologies), and 100 m/ml each
ng/ml TRITC-conjugated phalloidin (Sigma), and incubated for 30±60of penicillin G and streptomycin. CH7C17 is a Jurkat variant that
min at 48C in the dark. Following three washes with cold PBS/1%stably expresses an HA peptide (residues 307±319) specific TCR
BSA/0.1% NaN3, GFP-gated cells were analyzed by flow cytometry.(Hewitt et al., 1992). The EBV-transformed human B lymphoblastoid
cell line LG-2 was used as a source of mitomycin C±treated APCs.
Immunofluorescence MicroscopyCOS cells and simian virus 40 large T antigen±transfected 293 (293
Jurkat-TAg cells were transfected with the corresponding plasmids,T) cells were grown in DMEM (Life Technologies) supplemented with
harvested 2 days later, washed, fixed, and permeabilized as de-2 mM glutamine, 10% FBS, 1 mM sodium pyruvate, and the same
scribed above. The cells were incubated overnight at 48C with 1 mg/antibiotics. Cells in a logarithmic growth phase were transfected
ml of an anti-PKCu antibody in 50 ml of PBS/1% BSA, washedwith the indicated amounts of plasmid DNAs by electroporation as
three times in the same medium, and incubated for 30 min at roomdescribed previously (Villalba et al., 1999a).
temperature in the dark with FITC-conjugated goat anti-rabbit IgG
antibody (1:100 dilution; Cappel) to visualize PKCu. The cells wereLuciferase and b-Galactosidase Assays
stained in parallel with TRITC-phalloidin as described above. AfterTransfected Jurkat-TAg cells were harvested after 2 days, washed
three washes with ice-cold PBS/1% BSA, the cells were mountedtwice with PBS, lysed, and luciferase or b-galactosidase activities
on coverglasses using a SlowFade kit (Molecular Probes) and ana-in cell extracts were determined as described (Villalba et al., 1999a,
lyzed by conventional fluorescence microscopy or by confocal mi-unpublished data).
croscopy (MRC 1024S; Bio-Rad).
Immunoprecipitation and Immunoblotting Subcellular Fractionation
Cells were lysed in 1 ml lysis buffer (20 mM Tris±HCl [pH 7.5] 150 Cells were resuspended in ice-cold hypotonic buffer (42 mM KCl,
mM NaCl, 5 mM EDTA, 5 mM sodium pyrophosphate, 1 mM Na3VO4 10 mM HEPES [pH 7.4], 5 mM MgCl2, 10 mg/ml each aprotinin and
plus 1% Nonidet P-40 [NP-40] and 10 mg/ml each of aprotinin and leupeptin) and incubated on ice for 15 min. Cells were transferred
leupeptin) for 10 min on ice. After centrifugation (16,000 3 g, 10 min to a 1 ml syringe and sheared by being passed five times through
at 48C), the supernatants were incubated with optimal concentra- a 30 gauge needle. The lysates were centrifuged at 200 3 g for 10
tions of antibodies for 1 hr at 48C, followed by 30 ml of protein A/G- min to remove nuclei and cell debris, and the supernatant was col-
plus-agarose (Santa Cruz Biotechnology) and overnight incubation lected and centrifuged at 13,000 3 g for 60 min at 48C. The superna-
at 48C. Samples were washed four times in lysis buffer, precipitates tant (cytosol) was collected, and the pellet was resuspended in lysis
were dissolved in Laemmli buffer and resolved by SDS-polyacryl- buffer (20 mM Tris±HCl [pH 7.5], 150 mM NaCl, 1% NP-40, and 10
amide gel electrophoresis (PAGE). Electrophoresed samples were mg/ml each aprotinin and leupeptin), vortexed for 5 min at 48C, and
processed for Western blot analysis as previously described (Villalba centrifuged again at 13,000 3 g for 60 min at 48C. The supernatant
et al., 1999). representing the particulate (membrane) fraction was saved, and
the detergent-insoluble fraction (cytoskeleton) was resuspended in
Kinase Assays 1% SDS in water. Each fraction was then diluted to a final concentra-
For PKC assays, 20 3 106 Jurkat or 2 3 106 293 cells were lysed, tion of 13 Laemmli buffer and separated by SDS-PAGE.
and PKC was immunoprecipitated as described above. Immunopre-
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